chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Little soreness at the injection site; arm swelled at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little soreness at the injection site) and VACCINATION SITE SWELLING (arm swelled at injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION SITE PAIN (Little soreness at the injection site) and VACCINATION SITE SWELLING (arm swelled at injection site). In February 2021, VACCINATION SITE PAIN (Little soreness at the injection site) and VACCINATION SITE SWELLING (arm swelled at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.The patient  applied baking soda with water which resolved the reaction.    This case was linked to MOD-2021-077634 (Patient Link).
Mom reported he began running temp (101.0), didn't feel well so she took him to the emergency room.
O20.0 - Threatened miscarriage in early pregnancy VAGINAL BLEEDING - PREGNANT
I received the second dose of the Moderna COVID19 vaccine at approximately 2pm on 1/28/21. Starting at 10am the next morning I noticed I was feeling fatigued and my heart rate was starting to increase. By 11am, I was experiencing diffuse myalgia, fatigue, and malaise. By the time I went home at 11:30am, I had a fever to at least 101F, chills, body aches, and headache. I rested in bed the whole rest of the day and the night. I felt better taking Tylenol but it only relieved my fevers somewhat. I had no GI symptoms, rash, or difficulty breathing. By the next morning my fever had abated and my energy level much improved.
Information has been received from a registered pharmacist a concerning a 19 or 20 year old of age female pharmacy technician who on an unspecified date was vaccinated with a first dose of GARDASIL and on approximately 15-JUN-2008, one month ago, was vaccinated with the second dose of GARDASIL. On 15-JUL-2008, the patient experienced a seizure after administration of second dose of GARDASIL. The technician hit her head and urinated on herself during the seizure. The seizure occurred while she was working. Paramedics treated her. At the time of reporting, she was alert and improving (recovering). The pharmacist did not know if she was hospitalized. The seizure was considered to be disabling by the reporter. Additional information has been requested.
Patient developed difficulty swallowing within a few minutes of vaccine administration. She received 2 doses of epinephrine and 1 dose IM Benadryl. She was sent to the ER with EMS.
Patient received moderna vaccine on 3/17/21, 4/14/21 and 12/23/21. Presented to ER on 7/4/22. COVID positive on 7/5/22. Patient is an 84-year-old female who went to the emergency department secondary to worsening weakness and multiple falls.  Was found to have UA with infection and also positive for COVID-19.  Was admitted and appropriately isolated and monitored for hypoxia.  Her COVID-19 remained essentially asymptomatic throughout her hospital stay.  She was started on Rocephin for the UTI.  Culture showed contamination.  Physical therapy and occupational therapy were consulted.  She continued with a lot of weakness and at high risk for further falls.  It was felt she would benefit from nursing home placement for continued rehabilitation and close supervision.  She had complete her hospital course of isolation prior to being discharged to nursing home.  This was completed on 07/14/2022.  She was discharged to Nursing Home on the above date in stable condition.  Blood pressure medications were adjusted during hospitalization and control improved. Discharged on 7/15/22
after the initial vaccine he contracted CoVid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (after the initial vaccine he contracted CoVid) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Idiopathic thrombocytopenic purpura (deficiency from 4-16 years old.) and IgG subclass deficiency (IgG deficiency from 4-16 years old.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (after the initial vaccine he contracted CoVid). At the time of the report, COVID-19 (after the initial vaccine he contracted CoVid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by reporter No treatment medications provided by the reporter.  It was reported that the patient received COVID vaccine almost 4 weeks ago. A week after the initial vaccine he contracted COVID. He was scheduled for his second dose and he saw information that indicated that he should wait so he did not get sick again. Patient reported that when he asked the Dr he said he could come 3/10/22 so he thought he should ask directly with conflicting information.  Company comment: This spontaneous case concerns a 26-year-old male patient with a relevant medical history of IgG subclass deficiency, who experienced the unexpected non serious AESI of COVID-19, approximately 1 week after the first dose of mRNA- 1273 vaccine. Very limited information is available regarding clinical course. Previous history of IgG subclass deficiency might be a confounder. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 31-Jan-2022: Updated Reporter's details, Information about date of vaccine administration added; Sender's Comments: This spontaneous case concerns a 26-year-old male patient with a relevant medical history of IgG subclass deficiency, who experienced the unexpected non serious AESI of COVID-19, approximately 1 week after the first dose of mRNA- 1273 vaccine. Very limited information is available regarding clinical course. Previous history of IgG subclass deficiency might be a confounder. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.
Tested positive 08/08/2022 - I had chills with a fever. A headache, sore throat and body aches.  Tested positive again 11/07/2022 - I had a headache, a sore throat and mild body aches.
Patient had redness in both her cheeks after vaccine. Similar incident after the first vaccine.  States she took claritin before getting this second shot.  Patient feels fine otherwise. Denies chest pain, throat/tongue swelling/tingling or itching.
That night or the next day my left thigh was almost as sore as my arm. All discomfort subsided within a day or two. A month later, around May 20, I experienced severe shooting pain in my thigh. Then the same thing two weeks after that, on June 4. It would come and go for a few hours, and it was a 10 on a scale of 1 to 10. Since then just a little pain in my thigh, a 1 on a scale of 1 to 10.  I reported it to my doctor and he recommended I report it to VAERS.
Foot drop; pins and needles in her left leg/paresthesias; Nerve pain; Having trouble flexing her foot; weird headache; didn't feel well overall; aches and pains and bad headache with leg pain; This is a spontaneous report from a contactable consumer (patient parent). A 19-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in arm left on 24May2021 09:30 (Batch/Lot number was not reported) as 2nd dose, single for COVID-19 immunisation. Patient age at vaccination was 19 years old. Medical history included asthma, acne, patient diagnosed with COVID-19 prior to vaccination, she tested positive for COVID antibodies in Dec2019, known allergies to peanuts, some tree nuts, eucalyptus, tea tree oil. Historical vaccine included 1st dose of BNT162B2 on 03May2021 at 02:30 PM in left arm at age of 19 years old for COVID-19 immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included Multi-Vitamin, cetirizine hydrochloride (ZYRTEC), ascorbic acid (VITAMIN C), VITAMIN D, bifidobacterium lactis (PROBIOTIC), all for unknown indication from unknown date; Topical Skin Creams for acne from unknown date. Reporter's daughter did not begin to experience symptoms until she woke up the next morning. She had a weird headache and didn't feel well overall. She began to experience pins and needles in her left leg. She went to bed around 4:30 pm as she had aches and pains and bad headache with leg pain. On Wed, she called in sick to work and contacted her primary care physician's office who instructed her to go to the emergency room. She had nerve pain and was having trouble flexing her foot. The pain increased the next day and she again contacted her primary care's office and went to the emergency room again. Both times she was referred to a neurologist. She had blood work, ultrasound and x-ray of the leg. She prev (preventively) has surgery to the leg on 14Jun2021- compartment syndrome release & peroneal nerve release (she had exertional compartment syndrome w/ release to all 4 compartments). Yesterday (02Jun2021) the neuro recommended an EMG and the diagnosis on the form was left foot drop and paresthesias. Patient still had headache. The events resulted doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Treatment received for the adverse events was reported as blood work, X-ray and ultrasound, all on 02Jun2021, 3 PT (physical therapy) appointments. Adverse event start date: 25May2021 at 07:00 AM. Patient was not recovered from the events.  Information for lot number has been requested.
hives in the axillar area of the LUE appearing a few days later, painful, "raw," and itchy
My daughter recieved the 3rd dose of HPV with in 10 hours she was shaking throwing up and passed out.  We had to call 911.
Father notified Imms/clinic that child had a seizure app. 5 hrs after receiving vaccines. States child never had a seizure before. Called 911 pt. transported to hosp. battery of test given all results given were negative. Child observed at hosp./24 hour observation. No further s/s.
after 15 minutes started to feel light headed,  had patient lay down with feet up, VSS - 120/68, pulse 78 strong and regular, Resp 18 non labored, skin warm and dry,  sat up to take a drink of water as she was laying back down she started to have mild tremors of both arms and legs and then became rigid, pupils were dilated and non responsive to light, no verbal response,  VS continued to be stable, O2 98%.  Patient was transported to the local ED.  She was started to respond when the ambulance arrived and was able to walk to the gurney.
Pfizer 5-11 year dose given 0.2 ML to patient at visit once vaccine was given they realized they gave the patient the wrong pfizer for her age group
This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the parent. A 17-month-old male patient received BNT162b2 (BNT162B2), on 07Jul2022 at 16:15 as dose 1, single (Batch/Lot number: unknown), in left leg for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Dairy allergy" (unspecified if ongoing), notes: Dairy allergy, Severe dairy intolerance allergy and possibly celiac,(still going through testing); "Severe dairy intolerance allergy and possibly celiac" (unspecified if ongoing), notes: Severe dairy intolerance allergy and possibly celiac,(still going through testing). There were no concomitant medications. The following information was reported: PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (non-serious) with onset 07Jul2022 at 16:15, outcome "unknown", described as "vaccine location Left leg"; ABDOMINAL PAIN (non-serious) with onset 08Jul2022 at 22:00, outcome "recovered" (Jul2022), described as "belly pain/ pointed at abdomen crying"; CRYING (non-serious) with onset 08Jul2022 at 22:00, outcome "recovered" (Jul2022); EATING DISORDER (non-serious) with onset 08Jul2022 at 22:00, outcome "recovered" (Jul2022), described as "he would not eat or drink"; PYREXIA (non-serious) with onset 08Jul2022 at 22:00, outcome "recovered" (Jul2022), described as "running a fever of 102 Fahrenheit, by 37 hours it was 104.9 F."; VOMITING (non-serious) with onset 08Jul2022 at 22:00, outcome "recovered" (Jul2022), described as "two episodes of vomiting". The events "crying", "belly pain/ pointed at abdomen crying", "running a fever of 102 fahrenheit, by 37 hours it was 104.9 f.", "he would not eat or drink" and "two episodes of vomiting" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of crying, abdominal pain, pyrexia, eating disorder, vomiting. Additional information: The patient didn't receive any vaccines in four weeks and no other medication took. Patient not been tested covid prior to vaccination. At the 30-hour mark after received vaccine the patient started crying about belly pain (pointed at abdomen crying "owwie"), and at around 36 hours he started running a fever of 102 Fahrenheit, by 37 hours it was 104.9 F. We went to an urgent care at around 48 hours after vaccine due to the very high fever, his abdominal pain, and the fact that he would not eat or drink, and they did PCR testing for covid and other viruses and everything was negative. He also had two episodes of vomiting when his fever was around 104. After 24 hours of fever, the fever broke and went away and he seemed back to normal. The patient received the treatment ibuprofen and Tylenol. Post vaccine covid tested positive. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sore arm that day; body did not hurt as badly as it hurt when had COVID; They had the shot 21 days ago exactly today, the first shot,; run a fever that night; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm that day), PAIN (body did not hurt as badly as it hurt when had COVID), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (They had the shot 21 days ago exactly today, the first shot,) and PYREXIA (run a fever that night) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (had COVID diagnosis, testing and symptoms on 01Dec2020) on 01-Dec-2020.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm that day), PAIN (body did not hurt as badly as it hurt when had COVID), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (They had the shot 21 days ago exactly today, the first shot,) and PYREXIA (run a fever that night). On 03-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (They had the shot 21 days ago exactly today, the first shot,) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm that day), PAIN (body did not hurt as badly as it hurt when had COVID) and PYREXIA (run a fever that night) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-026193, MOD-2021-016551, MOD-2021-017943 (Patient Link).
The nurse providing the injection was standing next to the sitting patient.  The injection was placed into the joint space at the superior end of the humerus, far too superior to the appropriate location (mid-deltoid).  The patient suffered severe pain and limited ROM of the left arm for a week after the vaccination.
Patient unable to provide vaccine information but states that she is fully vaccinated and boosted. Patient tested positive for COVID on 8/13/22
High fever; Migraines; abdominal pain; shakes; inappropriate age at vaccination; This case was reported by a consumer via call center representative and described the occurrence of fever in a 34-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   Co-suspect products included Men B NVS (Bexsero) for prophylaxis and PNEUMOCOCCAL VACCINE (PNEUMOVAX) (batch number PPSV23, expiry date unknown) for prophylaxis.   Concurrent medical conditions included splenectomy.   On 22nd July 2019, the patient received Menveo, Bexsero and PNEUMOVAX. On 22nd July 2019, less than a day after receiving Menveo and Bexsero, the patient experienced fever (serious criteria hospitalization), migraine (serious criteria hospitalization), abdominal pain (serious criteria hospitalization), tremor (serious criteria hospitalization) and inappropriate age at vaccine administration. On an unknown date, the outcome of the fever, migraine, abdominal pain and tremor were recovered/resolved and the outcome of the inappropriate age at vaccine administration was unknown.   It was unknown if the reporter considered the fever, migraine, abdominal pain and tremor to be related to Menveo and Bexsero.  Additional details were provided as follows: The patient experienced high fever with shakes, migraines, and abdominal pain. The patient received Bexsero outside the recommended age, which led to inappropriate age at vaccine administration. On 24th July 2019, the patient was hospitalized. The reporter had to disconnect the call, so could not obtain additional information. The patient did not have a specific doctor and could not provide name of the health care professional to follow up. The reporter did not consent to follow-up. This case was medication error associated with adverse events. The outcome reported for all AES in the structured field of database is "recovered/resolved with sequel" instead of "recovered/resolved" (outcome uploaded in database).
Patient fainted, was out for approximately 5 minutes, complained of sore neck.  Patient refused ambulance
This case was reported by a physician to a sales representative and described the occurrence of an unspecified adverse event in a 68-year-old male subject who was vaccinated with Fluarix (GlaxoSmithKline). The subject's medical history, concurrent conditions, and concurrent medications were not reported. No other vaccines were reported to be administered on the date of receipt of Fluarix. On 16 November 2007 the subject received unspecified dose of Fluarix (unknown). The dose was recorded as the 1st dose of Fluarix, however, information regarding previous immunization with influenza virus vaccine was not provided. On 27 November 2007, 11 days after vaccination with Fluarix, the subject experienced an unspecified adverse event which required hospitalization, and product complaint. The reported adverse event was that a male subject was hospitalized and placed in an intensive care unit 11 days after vaccination with Fluarix. No specific adverse events were reported. The reporting physician is seeking a possible quality assurance issue with the vaccine as to the cause of the subject's hospitalization. The physician considered the events were disabling and life threatening as well as requiring hospitalization. At the time of reporting the events were unresolved. The physician considered the events were probably related to vaccination with Fluarix.
1st dose on 28-feb-20 didn´t get the 2nd yet; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 28th February 2020).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 23-JUN-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient was planning on getting the second today (on the day of reporting). The patient asked would it still be effective. Additional supportive information: Till the time of reporting the patient did not receive the 2nd dose of Shingrix, which led to Incomplete course of vaccination. The follow-up would not possible, as no contact, details were available.
Fever set in the next evening, on Saturday the 3rd. Lasted until Sunday the 4th. Injection site swelled up starting that Sunday, and lasted a week. Grew to be about grapefruit sized in diameter, raised out of the skin like a large lump. Was red, and painful to the touch. Shrunk slowly over the course of the week, while still remaining painful and red. Tomorrow will be 2 weeks from vaccination, a lump still remains in the arm. Redness is gone, and slight pain remains when touched.
DVT; BLOOD CLOT; This solicited report received from a lawyer, concerned a male of unspecified age, race and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administrated for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, 3 weeks after vaccination, the patient developed a blood clot and DVT (deep vein thrombosis). Treatment medications (dates unspecified) included: Xarelto (rivaroxaban). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the DVT and blood clot was not reported. The reporter provided no causality assessment. Company causality between covid-19 vaccine ad26.cov2.s, and DVT, and blood clot was related.  This report was serious (Other Medically Important Condition).; Sender's Comments: V0: Medical Assessment comment not required as per standard operating procedure for legal case.
2 days post 1st dose of vax noc sweats, fever x 5 days, tingling sensation in arm cont;still has problem w/arm;gets tired quickly;examined by MD
Sprawling rash on the left lower/middle back area noticed on the proceeding morning on 4/21. Taken tylenol three times in the course of past 12 days. Rash has gotten redder and sprawled a bit more to right side of back. I do not have a PCP, planning visit to urgent care this week.
My daughter got a really sore throat that night I took her to the walk in clinic the next day. They did a strep test on her it came back negative. Then this morning she  felt like puking in the night so she went up stairs and slept on the couch. When she woke up this morning she still wasn?t feeling well so she decided to take a shower and i was in the kitchen doing the dishes and heard her fall in the shower and then start crying so I ran in there and she was on the floor in the shower she said her hearing and eye sight went in and out then she passed out so I got her out of the shower and she started dry heaving and puked up bile. We sat there for a couple minutes and I called the dr on call at her Dr office which is pediatrics office. And Dr told me to report this to you guys and sent me this link. She is feeling completely fine now just really tired.